Welcome to the third-quarter issue of Clinical Insights in Eyecare for 2025. This issue includes 5 unique case reports, a clinically fascinating point-counterpoint discussion, and multiple journal scans.
Our featured case report in this issue is “Purtscher Retinopathy and Concurrent Paracentral Acute Middle Maculopathy from a Motor Vehicle Accident,” by Ana Rebeca P. Rego, OD, and Danielle L. Weiler, OD, FAAO, Dipl AAO, which underscores the importance of prompt multimodal imaging and careful systemic workup when evaluating trauma-induced retinal findings.
In the case report “Interstitial Keratitis in a Patient With Past History of Corneal Collagen Cross-Linking for Post-LASIK Keratectasia and Scleral Lens Wear,” Ben Connell, FRANZCO, MPH, Richard G Lindsay, MBA, FAAO, Dipl AAO, FCCLSA, FACO, Jessica T Chi, BOptom, and Penny McKelvie, MBBS, FRCPA, DMedSc highlight the development of interstitial keratitis, likely caused by scleral contact lens wear, years after LASIK and collagen cross-linking.
Another compelling case, “Management of Retinally Induced Aniseikonia,” by Celia Sze Kei Yeung, OD, FAAO, and Debora M. Lee Chen, OD, MPH, FAAO, Dipl AAO, provides a comprehensive review of diagnosis and treatment strategies, along with practical clinical considerations for improving patient visual function and quality of life.
The fourth case report, “Corneal Toxicity in Antibody-Drug Conjugate,” by William Skoog, OD, FAAO, explores the ocular surface complications associated with systemic therapies for multiple myeloma and highlights how careful monitoring can help optimize visual outcomes.
Our last case report, “VEXAS Syndrome Expands the List of Systemic Diseases Underlying Episcleritis,” by Michael L. Chang, OD, and Andrew B. Mick, OD, FAAO, examines a rare systemic inflammatory condition with ocular involvement, offering valuable insights into collaborative care between optometry and systemic medicine.
This issue’s Point-Counterpoint features an engaging discussion by Jay M. Haynie, OD, FAAO, and Jeff Gerson, OD, FAAO, examining the potential role of photobiomodulation as a novel treatment for dry age-related macular degeneration. The authors present well-balanced perspectives on the current evidence, clinical applicability, and future research needed to validate this emerging therapeutic option. This is a must-read for any clinician managing patients with age-related macular degeneration.
As always, Drew Rixon, OD, FAAO, and Eddie Chu, OD, FAAO, deliver insightful journal summaries and thoughtful reviews from recent publications in this month’s issue. Their reviews offer practical clinical takeaways on a range of topics, including diabetic retinal disease, glaucoma medications, and school-based vision screenings.
We hope you enjoy this issue!
Raman Bhakhri, OD, FAAO
Editor in Chief
Jim Williamson, OD, FAAO
Associate Editor